Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis

Abstract : Introduction: Regulatory T (Treg) cells play a crucial role in preventing autoimmune diseases and are an ideal target for the development of therapies designed to suppress inflammation in an antigen-specific manner. Type 1 regulatory T (Tr1) cells are defined by their capacity to produce high levels of interleukin 10 (IL-10), which contributes to their ability to suppress pathological immune responses in several settings. The aim of this study was to evaluate the therapeutic potential of collagen type II–specific Tr1 (Col-Treg) cells in two models of rheumatoid arthritis (RA) in mice. Methods: Col-Treg clones were isolated and expanded from collagen-specific TCR transgenic mice. Their cytokine secretion profile and phenotype characterization were studied. The therapeutic potential of Col-Treg cells was evaluated after adoptive transfer in collagen-antibody– and collagen-induced arthritis models. The in vivo suppressive mechanism of Col-Treg clones on effector T-cell proliferation was also investigated. Results: Col-Treg clones are characterized by their specific cytokine profile (IL-10highIL-4negIFN-γint) and mediate contact-independent immune suppression. They also share with natural Tregs high expression of GITR, CD39 and granzyme B. A single infusion of Col-Treg cells reduced the incidence and clinical symptoms of arthritis in both preventive and curative settings, with a significant impact on collagen type II antibodies. Importantly, injection of antigen-specific Tr1 cells decreased the proliferation of antigen-specific effector T cells in vivo significantly. Conclusions: Our results demonstrate the therapeutic potential of Col-Treg cells in two models of RA, providing evidence that Col-Treg could be an efficient cell-based therapy for RA patients whose disease is refractory to current treatments.
Type de document :
Article dans une revue
Liste complète des métadonnées

Littérature citée [55 références]  Voir  Masquer  Télécharger

https://hal.umontpellier.fr/hal-02397296
Contributeur : Anne-Laure Bonnefont <>
Soumis le : vendredi 6 décembre 2019 - 14:46:51
Dernière modification le : mardi 17 décembre 2019 - 02:26:20

Fichier

Version publiée AR4567.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Hélène Asnagli, Delphine Martire, Nathalie Belmonte, Julie Quentin, Hervé Bastian, et al.. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis. Arthritis Research and Therapy, BioMed Central, 2014, ⟨10.1186/ar4567⟩. ⟨hal-02397296⟩

Partager

Métriques

Consultations de la notice

24

Téléchargements de fichiers

19